Wang Xin, Yao Dong-Sheng, Xu Lin, Yan Dong-Ming, Zhao Yu, Peng Jing-Hua, Fu Qi-Lin, Hu Yi-Yang, Feng Qin
Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai, 201203, China.
Curr Med Sci. 2024 Dec;44(6):1241-1248. doi: 10.1007/s11596-024-2955-2. Epub 2024 Dec 2.
Jianpi huoxue decoction (JHD), a Chinese herbal formula, is commonly used for treating alcohol-associated liver disease (ALD). This study aimed to investigate the mechanism by which JHD affects intestinal barrier function in ALD rats.
The Sprague-Dawley rats were randomly divided into three groups: control group, model group and JHD group. They were pair-fed a modified Lieber-DeCarli liquid diet containing alcohol (model group, n=10; JHD group, n=10) or isocaloric maltose dextrin (control group, n=10) for 6 weeks. After 3 weeks of feeding, the mice in the JHD group were given JHD (10 mL/kg/day) by gavage for 3 weeks, and those in the control and model groups received equal amounts of double-distilled water for the same period of time. Afterwards, all the rats were given lipopolysaccharide (LPS) by gavage and sacrificed 3.5 h later. LPS levels were measured in the portal blood to evaluate gut leakage. Transmission electron microscopy (TEM) was used to observe ultrastructural changes in the intestinal tract. Adherens junction (AJ) and tight junction (TJ) proteins were detected by Western blotting, immunofluorescence or immunohistochemistry.
JHD ameliorated Lieber-DeCarli liquid diet-induced hepatic steatosis, inflammation and LPS expression. It improved pathological changes in the liver and alleviated intestinal ultrastructure injury. Moreover, it significantly enhanced the integrity of tight junctions by increasing the expression of zonula occludens-1 (ZO-1) and occludin. It suppressed the activation of myosin light chain (MLC) phosphorylation.
JHD improves intestinal barrier function and reduces gut leakiness in ALD rats.
健脾活血汤(JHD)是一种中药方剂,常用于治疗酒精性肝病(ALD)。本研究旨在探讨JHD影响ALD大鼠肠道屏障功能的机制。
将Sprague-Dawley大鼠随机分为三组:对照组、模型组和JHD组。对它们进行配对喂养,模型组(n = 10)和JHD组(n = 10)给予含酒精的改良Lieber-DeCarli液体饲料,对照组(n = 10)给予等热量的麦芽糖糊精,持续6周。喂养3周后,JHD组小鼠每天经口灌胃给予JHD(10 mL/kg),持续3周,而对照组和模型组小鼠在同一时期给予等量的双蒸水。之后,所有大鼠经口灌胃给予脂多糖(LPS),3.5小时后处死。检测门静脉血中LPS水平以评估肠道通透性。采用透射电子显微镜(TEM)观察肠道超微结构变化。通过蛋白质免疫印迹法、免疫荧光法或免疫组织化学法检测黏附连接(AJ)和紧密连接(TJ)蛋白。
JHD改善了Lieber-DeCarli液体饲料诱导的肝脏脂肪变性、炎症和LPS表达。它改善了肝脏的病理变化,减轻了肠道超微结构损伤。此外,它通过增加闭合蛋白-1(ZO-1)和闭合蛋白的表达显著增强了紧密连接的完整性。它抑制了肌球蛋白轻链(MLC)磷酸化的激活。
JHD改善了ALD大鼠的肠道屏障功能,降低了肠道通透性。